{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:36:25Z","timestamp":1782603385907,"version":"3.54.5"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11886-020-01389-9","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T09:47:38Z","timestamp":1599731258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Intensive Care Unit Management of the Adult with Congenital Heart Disease"],"prefix":"10.1007","volume":"22","author":[{"given":"Payton","family":"Kendsersky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3150-5215","authenticated-orcid":false,"given":"Richard A.","family":"Krasuski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"issue":"5","key":"1389_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/HCO.0000000000000429","volume":"32","author":"AN Thakkar","year":"2017","unstructured":"Thakkar AN, Chinnadurai P, Lin CH. Adult congenital heart disease. Curr Opin Cardiol. 2017;32(5):467\u201374. https:\/\/doi.org\/10.1097\/HCO.0000000000000429.","journal-title":"Curr Opin Cardiol"},{"issue":"1","key":"1389_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jjcc.2019.06.010","volume":"75","author":"A Mizuno","year":"2020","unstructured":"Mizuno A, Niwa K, Ochiai R, Shiraishi I, Sumita Y, Daida H, et al. Impact of facilities accredited by both adult and pediatric cardiology societies on the outcome of patients with adult congenital heart disease. J Cardiol. 2020;75(1):105\u20139.","journal-title":"J Cardiol"},{"key":"1389_CR3","doi-asserted-by":"crossref","unstructured":"\u2022 Agarwal S, Sud K, Menon V. Nationwide hospitalization trends in adult congenital heart disease across 2003\u20132012. J Am Heart Assoc. 2016;5(1) Trends in hospitalization, outcomes, and resource utilization among patients admitted with ACHD over one decade.","DOI":"10.1161\/JAHA.115.002330"},{"issue":"3","key":"1389_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00246-017-1770-y","volume":"39","author":"MD Seckeler","year":"2018","unstructured":"Seckeler MD, Thomas ID, Andrews J, Meziab O, Moe T, Heller E, et al. Higher cost of hospitalizations for non-cardiac diagnoses in adults with congenital heart disease. Pediatr Cardiol. 2018;39(3):437\u201344.","journal-title":"Pediatr Cardiol"},{"key":"1389_CR5","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Lui GK, Saidi A, Bhatt AB, Burchill LJ, Deen JF, Earing MG, et al. Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2017;136(20). https:\/\/doi.org\/10.1161\/cir.0000000000000535A comprehensive review identifying specific noncardiac comorbidities in ACHD patients. Provides framework for developing key collaborations with clinical services outside cardiology.","DOI":"10.1161\/cir.0000000000000535"},{"issue":"11","key":"1389_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/hrt.2009.185595","volume":"96","author":"CL Verheugt","year":"2010","unstructured":"Verheugt CL, Uiterwaal CSPM, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerda GT, et al. The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 2010;96(11):872\u20138.","journal-title":"Heart"},{"issue":"16","key":"1389_CR7","doi-asserted-by":"crossref","first-page":"e012595","DOI":"10.1161\/JAHA.119.012595","volume":"8","author":"A Agarwal","year":"2019","unstructured":"Agarwal A, Dudley CW, Nah G, Hayward R, Tseng ZH. Clinical outcomes during admissions for heart failure among adults with congenital heart disease. JAHA. 2019;8(16):e012595.","journal-title":"JAHA"},{"issue":"4","key":"1389_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ejhf.1051","volume":"20","author":"S Lal","year":"2018","unstructured":"Lal S, Kotchetkova I, Cao J, Jackson D, Cordina R, Celermajer DS. Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease. Eur J Heart Fail. 2018;20(4):812\u20135. https:\/\/doi.org\/10.1002\/ejhf.1051.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"1389_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ejhf.1236","volume":"20","author":"MG Crespo-Leiro","year":"2018","unstructured":"Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of cardiology. Eur J Heart Fail. 2018;20(11):1505\u201335. https:\/\/doi.org\/10.1002\/ejhf.1236.","journal-title":"Eur J Heart Fail"},{"key":"1389_CR10","doi-asserted-by":"publisher","unstructured":"Smith AM. The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension. QJM. n.d.;99(3):127\u201333. https:\/\/doi.org\/10.1093\/qjmed\/hcl009.","DOI":"10.1093\/qjmed\/hcl009"},{"issue":"2","key":"1389_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0883-9441(87)90174-2","volume":"2","author":"R Grose","year":"1987","unstructured":"Grose R, Strain J, Greenberg M. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure. J Crit Care. 1987;2(2):150. https:\/\/doi.org\/10.1016\/0883-9441(87)90174-2.","journal-title":"J Crit Care"},{"issue":"3","key":"1389_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/0885066606287039","volume":"21","author":"JR Egan","year":"2006","unstructured":"Egan JR, Clarke AJB, Williams S, Cole AD, Ayer J, Jacobe S, et al. Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med. 2006;21(3):183\u20137. https:\/\/doi.org\/10.1177\/0885066606287039.","journal-title":"J Intensive Care Med"},{"issue":"2","key":"1389_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pharmthera.2007.01.008","volume":"114","author":"C Antoniades","year":"2007","unstructured":"Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C. Levosimendan: beyond its simple inotropic effect in heart failure. Pharmacol Ther. 2007;114(2):184\u201397. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.01.008.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"1389_CR14","doi-asserted-by":"publisher","first-page":"204589401879090","DOI":"10.1177\/2045894018790905","volume":"8","author":"MS Hansen","year":"2018","unstructured":"Hansen MS, Andersen A, Nielsen-Kudsk JE. Levosimendan in pulmonary hypertension and right heart failure. Pulm Circ. 2018;8(3):204589401879090.","journal-title":"Pulm Circ"},{"key":"1389_CR15","doi-asserted-by":"publisher","unstructured":"Serfas JD, Patel PA, Krasuski RA. Heart transplantation and mechanical circulatory support in adults with congenital heart disease. Curr Cardiol Rep. 2018;20(10). https:\/\/doi.org\/10.1007\/s11886-018-1028-1.","DOI":"10.1007\/s11886-018-1028-1"},{"issue":"9","key":"1389_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jacc.2016.05.082","volume":"68","author":"LI Alshawabkeh","year":"2016","unstructured":"Alshawabkeh LI, Hu N, Carter KD, Opotowsky AR, Light-McGroary K, Cavanaugh JE, et al. Wait-list outcomes for adults with congenital heart disease listed for heart transplantation in the U.S. J Am Coll Cardiol. 2016;68(9):908\u201317. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.082.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1389_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/chd.12396","volume":"11","author":"B Acheampong","year":"2016","unstructured":"Acheampong B, Johnson JN, Stulak JM, Dearani JA, Kushwaha SS, Daly RC, et al. Postcardiotomy ECMO support after high-risk operations in adult congenital heart disease. Congenit Heart Dis. 2016;11(6):751\u20135. https:\/\/doi.org\/10.1111\/chd.12396.","journal-title":"Congenit Heart Dis"},{"issue":"3","key":"1389_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1161\/circulationaha.118.038201","volume":"139","author":"H Thiele","year":"2019","unstructured":"Thiele H, Zeymer U, Thelemann N, Neumann F-J, Hausleiter J, Abdel-Wahab M, et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction. Circulation. 2019;139(3):395\u2013403. https:\/\/doi.org\/10.1161\/circulationaha.118.038201.","journal-title":"Circulation"},{"issue":"7","key":"1389_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.cjca.2013.02.008","volume":"29","author":"C VanderPluym","year":"2013","unstructured":"VanderPluym C, Urschel S, Buchholz H. Advanced therapies for congenital heart disease: ventricular assist devices and heart transplantation. Can J Cardiol. 2013;29(7):796\u2013802.","journal-title":"Can J Cardiol"},{"issue":"2","key":"1389_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1054\/jcaf.2002.32944","volume":"8","author":"SA Hunt","year":"2002","unstructured":"Hunt SA, EA, R. The REMATCH trial: long-term use of a left ventricular assist device for end-stage heart failure. J Card Fail. 2002;8(2):59\u201360. https:\/\/doi.org\/10.1054\/jcaf.2002.32944.","journal-title":"J Card Fail"},{"issue":"1","key":"1389_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.healun.2017.03.005","volume":"37","author":"A Cedars","year":"2018","unstructured":"\u2022 Cedars A, VanderPluym CJ, Eghtesady P, Maxwell BG, Gelow JM, Burchill LJ, et al. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). J Heart Lung Transplant. 2018a;37(1):89\u201399. https:\/\/doi.org\/10.1016\/j.healun.2017.03.005An analysis of INTERMACS data demonstrating similar mortality for ACHD patients on LVAD support compared with non-ACHD patients on LVAD support.","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"1389_CR22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/ejcts\/ezt498","volume":"45","author":"BG Maxwell","year":"2014","unstructured":"Maxwell BG, Wong JK, Sheikh AY, Lee PH, Lobato RL. Heart transplantation with or without prior mechanical circulatory support in adults with congenital heart disease. Eur J Cardiothorac Surg. 2014;45(5):842\u20136. https:\/\/doi.org\/10.1093\/ejcts\/ezt498.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"1389_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.21037\/acs.2018.01.01","volume":"7","author":"R Bryant III","year":"2018","unstructured":"Bryant R III, Morales D. Overview of adult congenital heart transplants. Ann Cardiothorac Surg. 2018;7(1):143\u201351. https:\/\/doi.org\/10.21037\/acs.2018.01.01.","journal-title":"Ann Cardiothorac Surg"},{"issue":"12","key":"1389_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11936-015-0418-6","volume":"17","author":"I Lindsay","year":"2015","unstructured":"Lindsay I, Moore JP. Cardiac arrhythmias in adults with congenital heart disease: scope, specific problems, and management. Curr Treat Options Cardio Med. 2015;17(12):56.","journal-title":"Curr Treat Options Cardio Med"},{"key":"1389_CR25","doi-asserted-by":"publisher","unstructured":"Grubb A, Krasuski RA. Don\u2019t call the electrician when the problem is the plumbing: resolution of paroxysmal atrial fibrillation with aggressive treatment of pulmonary hypertension. AMSRJ. n.d.;1(2). https:\/\/doi.org\/10.15422\/amsrj.2015.03.021.","DOI":"10.15422\/amsrj.2015.03.021"},{"issue":"6","key":"1389_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00246-007-9005-2","volume":"28","author":"BJ Deal","year":"2007","unstructured":"Deal BJ, Mavroudis C, Backer CL. Arrhythmia management in the Fontan patient. Pediatr Cardiol. 2007;28(6):448\u201356. https:\/\/doi.org\/10.1007\/s00246-007-9005-2.","journal-title":"Pediatr Cardiol"},{"key":"1389_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijcard.2015.03.157","volume":"187","author":"MK Song","year":"2015","unstructured":"Song MK, Bae EJ, Kwon BS, Kim GB, Noh CI, Choi JY, et al. Intra-atrial reentrant tachycardia in adult patients after Fontan operation. Int J Cardiol. 2015;187:157\u201363. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.157.","journal-title":"Int J Cardiol"},{"issue":"9","key":"1389_CR28","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCULATIONAHA.109.928481","volume":"122","author":"P Khairy","year":"2010","unstructured":"Khairy P, Aboulhosn J, Gurvitz MZ, Opotowsky AR, Mongeon F-P, Kay J, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot. Circulation. 2010;122(9):868\u201375.","journal-title":"Circulation"},{"issue":"19","key":"1389_CR29","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/0002-9149(89)90573-0","volume":"64","author":"C Garratt","year":"1989","unstructured":"Garratt C, Linker N, Griffith M, Ward D, Camm AJ. Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia. Am J Cardiol. 1989;64(19):1310\u20136. https:\/\/doi.org\/10.1016\/0002-9149(89)90573-0.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1389_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.cir.100.2.149","volume":"100","author":"SA Thorne","year":"1999","unstructured":"Thorne SA, Barnes I, Cullinan P, Somerville J. Amiodarone-associated thyroid dysfunction. Circulation. 1999;100(2):149\u201354. https:\/\/doi.org\/10.1161\/01.cir.100.2.149.","journal-title":"Circulation"},{"issue":"6","key":"1389_CR31","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/s0735-1097(01)01192-5","volume":"37","author":"E Delacretaz","year":"2001","unstructured":"Delacretaz E, Ganz LI, Soejima K, Friedman PL, Walsh EP, Triedman JK, et al. Multiple atrial macro-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol. 2001;37(6):1665\u201376. https:\/\/doi.org\/10.1016\/s0735-1097(01)01192-5.","journal-title":"J Am Coll Cardiol"},{"key":"1389_CR32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ijcard.2016.08.223","volume":"223","author":"P Khairy","year":"2016","unstructured":"Khairy P, Aboulhosn J, Broberg CS, Cohen S, Cook S, Dore A, et al. Thromboprophylaxis for atrial arrhythmias in congenital heart disease: a multicenter study. Int J Cardiol. 2016;223:729\u201335. https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.223.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1389_CR33","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/circep.113.001321","volume":"7","author":"MR Williams","year":"2014","unstructured":"Williams MR, Shepard SM, Boramanand NK, Lamberti JJ, Perry JC. Long-term follow-up shows excellent transmural atrial lead performance in patients with complex congenital heart disease. Circ Arrhythm Electrophysiol. 2014;7(4):652\u20137. https:\/\/doi.org\/10.1161\/circep.113.001321.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"1389_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.hrcr.2016.07.006","volume":"2","author":"E O\u2019Leary","year":"2016","unstructured":"O\u2019Leary E, Alexander ME, Fynn-Thompson F, Mah D. Transvenous approach to pacemaker lead implantation for sinus node dysfunction after extracardiac lateral tunnel Fontan conduit placement. Heart Rhythm Case Reps. 2016;2(6):495\u20138. https:\/\/doi.org\/10.1016\/j.hrcr.2016.07.006.","journal-title":"Heart Rhythm Case Reps"},{"issue":"10","key":"1389_CR35","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/j.hrthm.2014.05.008","volume":"11","author":"P Khairy","year":"2014","unstructured":"Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES\/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: executive summary. Heart Rhythm. 2014;11(10):e81\u2013e101.","journal-title":"Heart Rhythm"},{"key":"1389_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijcard.2017.08.035","volume":"249","author":"B Moore","year":"2017","unstructured":"Moore B, Cao J, Kotchetkova I, Celermajer DS. Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population. Int J Cardiol. 2017;249:161\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2017.08.035.","journal-title":"Int J Cardiol"},{"key":"1389_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ahj.2019.05.014","volume":"215","author":"T Cahill","year":"2019","unstructured":"Cahill T, Jewell P, Denne L, Franklin R, Frigiola A, Orchard E, et al. Contemporary epidemiology of infective endocarditis in patients with congenital heart disease: a UK prospective study. Am Heart J. 2019;215:70\u20137. https:\/\/doi.org\/10.1016\/j.ahj.2019.05.014.","journal-title":"Am Heart J"},{"issue":"2","key":"1389_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/heartjnl-2017-311650","volume":"104","author":"O Tutarel","year":"2018","unstructured":"Tutarel O, Alonso-Gonzalez R, Montanaro C, Schiff R, Uribarri A, Kempny A, et al. Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart. 2018;104(2):161\u20135. https:\/\/doi.org\/10.1136\/heartjnl-2017-311650.","journal-title":"Heart"},{"issue":"2","key":"1389_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijcard.2004.03.035","volume":"101","author":"W Knirsch","year":"2005","unstructured":"Knirsch W, Haas NA, Uhlemann F, Dietz K, Lange PE. Clinical course and complications of infective endocarditis in patients growing up with congenital heart disease. Int J Cardiol. 2005;101(2):285\u201391. https:\/\/doi.org\/10.1016\/j.ijcard.2004.03.035.","journal-title":"Int J Cardiol"},{"key":"1389_CR40","doi-asserted-by":"publisher","unstructured":"Di Filippo S. Current patterns of infective endocarditis in congenital heart disease. Heart. n.d.;92(10):1490\u20135. https:\/\/doi.org\/10.1136\/hrt.2005.085332.","DOI":"10.1136\/hrt.2005.085332"},{"key":"1389_CR41","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1253\/circj.69.1266","volume":"69","author":"N Ishiwada","year":"2005","unstructured":"Ishiwada N, Niwa K, Tateno S, Yoshinaga M, Terai M, Nakazawa M, et al. Causative organism influences clinical profile and outcome of infective endocarditis in pediatric patients and adults with congenital heart disease. Circ J. 2005;69:1266\u201370.","journal-title":"Circ J"},{"key":"1389_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0002-9149(74)90099-X","volume":"34","author":"CA Fischbein","year":"1974","unstructured":"Fischbein CA, Rosenthal A, Fischer EG, Nadas AS, Welch K. Risk factors of brain abscess in patients with congenital heart disease. Am J Cardiol. 1974;34:97\u2013102.","journal-title":"Am J Cardiol"},{"key":"1389_CR43","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3171\/jns.1983.58.6.0913","volume":"58","author":"M Kagawa","year":"1983","unstructured":"Kagawa M, Takeshita M, Yato S, Kitamura K. Brain abscess in congenital cyanotic heart disease. J Neurosurg. 1983;58:913\u20137.","journal-title":"J Neurosurg"},{"key":"1389_CR44","doi-asserted-by":"crossref","unstructured":"Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020). Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med.","DOI":"10.1007\/s00134-020-05991-x"},{"key":"1389_CR45","doi-asserted-by":"crossref","unstructured":"Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., et al. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med.","DOI":"10.1001\/jamainternmed.2020.0994"},{"issue":"10229","key":"1389_CR46","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"key":"1389_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijcard.2020.03.063","volume":"309","author":"W Tan","year":"2020","unstructured":"Tan W, Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol. 2020;309:70\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2020.03.063.","journal-title":"Int J Cardiol"},{"issue":"13","key":"1389_CR48","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020;323(13):1239. https:\/\/doi.org\/10.1001\/jama.2020.2648.","journal-title":"JAMA"},{"key":"1389_CR49","doi-asserted-by":"publisher","unstructured":"Roca E, Lombardi C, Campana M, Vivaldi O, Bigni B, Bertozzi B, et al. Takotsubo syndrome associated with COVID-19. 2020;7(5):1. https:\/\/doi.org\/10.12890\/2020_001665.","DOI":"10.12890\/2020_001665"},{"issue":"10239","key":"1389_CR50","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/s0140-6736(20)31129-6","volume":"395","author":"RM Viner","year":"2020","unstructured":"Viner RM, Whittaker E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet. 2020;395(10239):1741\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(20)31129-6.","journal-title":"Lancet"},{"key":"1389_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.amjcard.2020.05.038","volume":"130","author":"MS Usman","year":"2020","unstructured":"Usman MS, Siddiqi TJ, Khan MS, Ahmed A, Ali SS, Michos ED, et al. A meta-analysis of the relationship between renin-angiotensin-aldosterone system inhibitors and COVID-19. Am J Cardiol. 2020;130:159\u201361. https:\/\/doi.org\/10.1016\/j.amjcard.2020.05.038.","journal-title":"Am J Cardiol"},{"key":"1389_CR52","unstructured":"American Heart Association. HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-19. European Society of Cardiology. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. Published March 13, 2020."},{"issue":"7","key":"1389_CR53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.tcm.2016.04.004","volume":"26","author":"SA Gaeta","year":"2016","unstructured":"Gaeta SA, Ward C, Krasuski RA. Extra-cardiac manifestations of adult congenital heart disease. Trends Cardiovasc Med. 2016;26(7):627\u201336. https:\/\/doi.org\/10.1016\/j.tcm.2016.04.004.","journal-title":"Trends Cardiovasc Med"},{"issue":"7","key":"1389_CR54","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/s0735-1097(00)00994-3","volume":"36","author":"RA Krasuski","year":"2000","unstructured":"Krasuski RA, Warner JJ, Wang A, Harrison JK, Tapson VF, Bashore TM. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. J Am Coll Cardiol. 2000;36(7):2204\u201311. https:\/\/doi.org\/10.1016\/s0735-1097(00)00994-3.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1389_CR55","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.cjca.2013.04.018","volume":"29","author":"SL Roche","year":"2013","unstructured":"Roche SL, Redington AN. The failing right ventricle in congenital heart disease. Can J Cardiol. 2013;29(7):768\u201378.","journal-title":"Can J Cardiol"},{"issue":"4","key":"1389_CR56","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s00246-012-0590-3","volume":"34","author":"P Gupta","year":"2013","unstructured":"Gupta P, Kuperstock JE, Hashmi S, Arnolde V, Gossett JM, Prodhan P, et al. Efficacy and predictors of success of noninvasive ventilation for prevention of extubation failure in critically ill children with heart disease. Pediatr Cardiol. 2013;34(4):964\u201377.","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"1389_CR57","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.jvca.2012.04.009","volume":"26","author":"CG Weismann","year":"2012","unstructured":"Weismann CG, Yang SF, Bodian C, Hollinger I, Nguyen K, Mittnacht AJC. Early extubation in adults undergoing surgery for congenital heart disease. J Cardiothorac Vasc Anesth. 2012;26(5):773\u20136. https:\/\/doi.org\/10.1053\/j.jvca.2012.04.009.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"8","key":"1389_CR58","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/MPH.0000000000001115","volume":"40","author":"JL Rodr\u00edguez-Hern\u00e1ndez","year":"2018","unstructured":"Rodr\u00edguez-Hern\u00e1ndez JL, Rodr\u00edguez-Gonz\u00e1lez F, Mart\u00ednez-Quintana E. Anemia in adolescents and young adult patients with congenital heart disease. J Pediatr Hematol Oncol. 2018;40(8):620\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"22","key":"1389_CR59","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.jacc.2009.06.050","volume":"54","author":"K Dimopoulos","year":"2009","unstructured":"Dimopoulos K, Diller G-P, Giannakoulas G, Petraco R, Chamaidi A, Karaoli E, et al. Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol. 2009;54(22):2093\u2013100. https:\/\/doi.org\/10.1016\/j.jacc.2009.06.050.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"1389_CR60","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jacc.2013.07.019","volume":"62","author":"JA Eindhoven","year":"2013","unstructured":"Eindhoven JA, van den Bosch AE, Ruys TPE, Opi\u0107 P, Cuypers JAAE, McGhie JS, et al. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol. 2013;62(13):1203\u201312. https:\/\/doi.org\/10.1016\/j.jacc.2013.07.019.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1389_CR61","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/j.ijcard.2012.06.019","volume":"167","author":"AS Jensen","year":"2013","unstructured":"Jensen AS, Johansson PI, Bochsen L, Idorn L, S\u00f8rensen KE, Thil\u00e9n U, et al. Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease. Int J Cardiol. 2013;167(5):2210\u20134.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1389_CR62","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.amjcard.2006.01.083","volume":"98","author":"MC Lill","year":"2006","unstructured":"Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol. 2006;98(2):254\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2006.01.083.","journal-title":"Am J Cardiol"},{"issue":"12","key":"1389_CR63","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s11606-007-0356-4","volume":"22","author":"SS Rose","year":"2007","unstructured":"Rose SS, Shah AA, Hoover DR, Saidi P. Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis. J Gen Intern Med. 2007;22(12):1775\u20137. https:\/\/doi.org\/10.1007\/s11606-007-0356-4.","journal-title":"J Gen Intern Med"},{"key":"1389_CR64","doi-asserted-by":"publisher","unstructured":"Ammash, MD, N. (1996). Cerebrovascular events in adult patients with cyanotic congenital heart disease 28(3), 768\u2013772. https:\/\/doi.org\/10.1016\/s0735-1097(96)00196-9.","DOI":"10.1016\/s0735-1097(96)00196-9"},{"key":"1389_CR65","doi-asserted-by":"publisher","unstructured":"Silvey M, Brand\u00e3o LR. Risk factors, prophylaxis, and treatment of venous thromboembolism in congenital heart disease patients. Front Pediatr. 2017;5. https:\/\/doi.org\/10.3389\/fped.2017.00146.","DOI":"10.3389\/fped.2017.00146"},{"issue":"1","key":"1389_CR66","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00246-011-0098-2","volume":"33","author":"SJ Hanson","year":"2012","unstructured":"Hanson SJ, Punzalan RC, Christensen MA, Ghanayem NS, Kuhn EM, Havens PL. Incidence and risk factors for venous thromboembolism in critically ill children with cardiac disease. Pediatr Cardiol. 2012;33(1):103\u20138. https:\/\/doi.org\/10.1007\/s00246-011-0098-2.","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"1389_CR67","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.healun.2012.02.003","volume":"31","author":"KE Simpson","year":"2012","unstructured":"Simpson KE, Cibulka N, Lee CK, Huddleston CH, Canter CE. Failed Fontan heart transplant candidates with preserved vs impaired ventricular ejection: 2 distinct patient populations. J Heart Lung Transplant. 2012;31(5):545\u20137. https:\/\/doi.org\/10.1016\/j.healun.2012.02.003.","journal-title":"J Heart Lung Transplant"},{"issue":"19","key":"1389_CR68","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1136\/heartjnl-2015-307657","volume":"101","author":"AS Jensen","year":"2015","unstructured":"Jensen AS, Idorn L, Thomsen C, von der Recke P, Mortensen J, S\u00f8rensen KE, et al. Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease. Heart. 2015;101(19):1540\u20136. https:\/\/doi.org\/10.1136\/heartjnl-2015-307657.","journal-title":"Heart"},{"issue":"2","key":"1389_CR69","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/jcm9020418","volume":"9","author":"T Alsaied","year":"2020","unstructured":"Alsaied T, Possner M, Lubert AM, Trout AT, Gandhi JP, Garr B, et al. Thromboembolic events are independently associated with liver stiffness in patients with Fontan circulation. JCM. 2020;9(2):418.","journal-title":"JCM"},{"issue":"11","key":"1389_CR70","doi-asserted-by":"publisher","first-page":"e0225403","DOI":"10.1371\/journal.pone.0225403","volume":"14","author":"R Konno","year":"2019","unstructured":"Konno R, Tatebe S, Sugimura K, Satoh K, Aoki T, Miura M, et al. Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease. PLoS One. 2019;14(11):e0225403.","journal-title":"PLoS One"},{"key":"1389_CR71","doi-asserted-by":"publisher","unstructured":"Opotowsky AR, Baraona F, Owumi J, Loukas B, Singh MN, Valente AM, et al. Galectin-3 is elevated and associated with adverse outcomes in patients with single-ventricle Fontan circulation. JAHA. 2016;5(1). https:\/\/doi.org\/10.1161\/jaha.115.002706.","DOI":"10.1161\/jaha.115.002706"},{"key":"1389_CR72","doi-asserted-by":"crossref","unstructured":"Ohuchi, H., Hayama, Y., Miike, H., Suzuki, D., Nakajima, K., Iwasa, T., Konagai, N., et al. (2020). Prognostic value of von Willebrand factor in adult patients with congenital heart disease. Heart, heartjnl-2019-316007.","DOI":"10.1136\/heartjnl-2019-316007"},{"issue":"1","key":"1389_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/chd.12169","volume":"10","author":"AB Bhatt","year":"2015","unstructured":"Bhatt AB, Rajabali A, He W, Benavidez OJ. High resource use among adult congenital heart surgery admissions in adult hospitals: risk factors and association with death and comorbidities. Congenit Heart Dis. 2015;10(1):13\u201320.","journal-title":"Congenit Heart Dis"},{"issue":"18","key":"1389_CR74","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1161\/circulationaha.107.734921","volume":"117","author":"K Dimopoulos","year":"2008","unstructured":"Dimopoulos K, Diller G-P, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117(18):2320\u20138. https:\/\/doi.org\/10.1161\/circulationaha.107.734921.","journal-title":"Circulation"},{"issue":"1","key":"1389_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/ajkd.2000.8237","volume":"36","author":"E Coll","year":"2000","unstructured":"Coll E, Botey A, Alvarez L, Poch E, Quint\u00f3 L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36(1):29\u201334. https:\/\/doi.org\/10.1053\/ajkd.2000.8237.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1389_CR76","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1747-0803.2012.00662.x","volume":"7","author":"MW Buelow","year":"2012","unstructured":"Buelow MW, Dall A, Regner K, Weinberg C, Bartz PJ, Sowinski J, et al. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine. Congenit Heart Dis. 2012;7(5):441\u20137. https:\/\/doi.org\/10.1111\/j.1747-0803.2012.00662.x.","journal-title":"Congenit Heart Dis"},{"issue":"2","key":"1389_CR77","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/chd.12433","volume":"12","author":"YY Kim","year":"2017","unstructured":"Kim YY, He W, MacGillivray TE, Benavidez OJ. Readmissions after adult congenital heart surgery: frequency and risk factors. Congenit Heart Dis. 2017;12(2):159\u201365. https:\/\/doi.org\/10.1111\/chd.12433.","journal-title":"Congenit Heart Dis"},{"issue":"1","key":"1389_CR78","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00246-011-0093-7","volume":"33","author":"MO Vogt","year":"2012","unstructured":"Vogt MO, H\u00f6rer J, Gr\u00fcnewald S, Otto D, Kaemmerer H, Schreiber C, et al. Independent risk factors for cardiac operations in adults with congenital heart disease: a retrospective study of 543 operations for 500 patients. Pediatr Cardiol. 2012;33(1):75\u201382.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"1389_CR79","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.athoracsur.2011.03.102","volume":"92","author":"KA Holst","year":"2011","unstructured":"Holst KA, Dearani JA, Burkhart HM, Connolly HM, Warnes CA, Li Z, et al. Risk factors and early outcomes of multiple reoperations in adults with congenital heart disease. Ann Thorac Surg. 2011;92(1):122\u201330.","journal-title":"Ann Thorac Surg"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01389-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-020-01389-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01389-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:02:07Z","timestamp":1744178527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-020-01389-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1007\/s11886-020-01389-9","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"assertion":[{"value":"10 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Krasuski serves as a consultant for Actelion Pharmaceuticals. He receives research funding from Actelion and the Adult Congenital Heart Association. He serves as an investigator for Edwards Lifesciences and Corvia Medical. He has received travel grants from Medtronic and CryoLife. Dr. Kendsersky reports no potential conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"136"}}